Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
SYSTEM FOR EARLY DIAGNOSIS OF PROSTATE CANCER
Document Type and Number:
WIPO Patent Application WO/2022/257955
Kind Code:
A1
Abstract:
A system for early diagnosis of prostate cancer, comprising: multiple medical devices used for testing a patient to obtain test data related to one or more of prostate cancer diseases; and a computer device used for analyzing patient data obtained from the multiple medical devices and analyzing the test data by using a corresponding machine learning-based analysis technique to generate a diagnosis result, the diagnosis result being used for determining whether the patient suffers from prostate cancer. According to the present invention, early diagnosis of prostate cancer is performed on a patient by means of a machine learning method in combination with an approach of detecting the number of circulating tumor cells (CTCs) and prostate-specific antibody PSA-related parameters PSA, F/T-PSA, and PSAD in the blood; in particular, early diagnosis is performed on patients whose T-PSA content is in a gray area of 4-10 ng/mL, such that the accuracy of early diagnosis and specificity are improved, non-invasive diagnosis is achieved, and overtest and overtreatment are avoided to a great extent.

Inventors:
WANG SHUTAO (CN)
MA LULIN (CN)
MENG JINGXIN (CN)
ZHANG SHUDONG (CN)
WANG BINSHUAI (CN)
BAO HAN (CN)
Application Number:
PCT/CN2022/097578
Publication Date:
December 15, 2022
Filing Date:
June 08, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
TECHNICAL INST OF PHYSICS AND CHEMISTRY OF THE CHINESE ACADEMY OF SCIENCES (CN)
International Classes:
G16H50/20
Foreign References:
US20090212551A12009-08-27
CN101632604A2010-01-27
CN106367476A2017-02-01
Attorney, Agent or Firm:
BEIJING JANLEA PATENT AGENCY CO., LTD. (CN)
Download PDF: